Skip to content

Advantages of single-use in cell and gene therapy manufacturing platforms

Experts from Watson-Marlow Fluid Technology Solutions and National Institute for Bioprocessing Research and Training (NIBRT) discuss the advantages of single-use technologies in CGT manufacturing platforms.

Advantages of single-use in cell and gene therapy manufacturing platforms
Published: | 4 min read

Dr. Alex Van Hagen, Life Sciences Sector specialist, Watson-Marlow Fluid Technology Solutions; James Drinkwater, head of GMP Compliance, Franz Ziel GmbH and Dr. John Milne, director of Training and Education, National Institute for Bioprocessing Research and Training (NIBRT), discuss the advantages of single-use technologies in CGT manufacturing platforms.

Harriet Wills (WMFTS UK)

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information